BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 15124117)

  • 1. [Utrophin, a way to cure Duchenne muscle dystrophy].
    Gillis JM
    Med Sci (Paris); 2004 Apr; 20(4):442-7. PubMed ID: 15124117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice.
    Gillis JM
    Acta Neurol Belg; 2000 Sep; 100(3):146-50. PubMed ID: 11098286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy.
    Chaubourt E; Fossier P; Baux G; Leprince C; Israƫl M; De La Porte S
    Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of full-length utrophin prevents muscular dystrophy in mdx mice.
    Tinsley J; Deconinck N; Fisher R; Kahn D; Phelps S; Gillis JM; Davies K
    Nat Med; 1998 Dec; 4(12):1441-4. PubMed ID: 9846586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
    Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
    Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG; Wehling-Henricks M
    Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.
    Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE
    Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Future treatment modalities in Duchenne muscular dystrophy].
    Oron A; Shuper A; Shohat M
    Harefuah; 1998 Apr; 134(7):557-60. PubMed ID: 10909603
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficient utrophin expression following adenovirus gene transfer in dystrophic muscle.
    Gilbert R; Nalbanoglu J; Tinsley JM; Massie B; Davies KE; Karpati G
    Biochem Biophys Res Commun; 1998 Jan; 242(1):244-7. PubMed ID: 9439643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
    Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine.
    Takahashi J; Itoh Y; Fujimori K; Imamura M; Wakayama Y; Miyagoe-Suzuki Y; Takeda S
    J Gene Med; 2005 Feb; 7(2):237-48. PubMed ID: 15538725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
    Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA
    Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice.
    Deconinck N; Tinsley J; De Backer F; Fisher R; Kahn D; Phelps S; Davies K; Gillis JM
    Nat Med; 1997 Nov; 3(11):1216-21. PubMed ID: 9359695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
    Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
    J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy.
    Krag TO; Gyrd-Hansen M; Khurana TS
    Acta Physiol Scand; 2001 Mar; 171(3):349-58. PubMed ID: 11412148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophin and utrophin: genetic analyses of their role in skeletal muscle.
    Rafael JA; Brown SC
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):155-66. PubMed ID: 10679963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?
    Miura P; Jasmin BJ
    Trends Mol Med; 2006 Mar; 12(3):122-9. PubMed ID: 16443393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle.
    Tanihata J; Suzuki N; Miyagoe-Suzuki Y; Imaizumi K; Takeda S
    J Gene Med; 2008 Jun; 10(6):702-13. PubMed ID: 18338831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the cardiac sodium channel Nav1.5 by utrophin in dystrophin-deficient mice.
    Albesa M; Ogrodnik J; Rougier JS; Abriel H
    Cardiovasc Res; 2011 Feb; 89(2):320-8. PubMed ID: 20952415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice.
    Porter JD; Merriam AP; Khanna S; Andrade FH; Richmonds CR; Leahy P; Cheng G; Karathanasis P; Zhou X; Kusner LL; Adams ME; Willem M; Mayer U; Kaminski HJ
    FASEB J; 2003 May; 17(8):893-5. PubMed ID: 12670877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.